Asset Entities Inc. SEC Filings

Matthew Ryan Cole, the Chief Executive Officer and a director of Strive, Inc. (ASST), reported multiple transactions related to Restricted Stock Units and common stock on October 1, 2025 (with one item dated September 12, 2025). Time‑ and performance‑based Restricted Stock Units vested and were settled into 18,459,504 shares of Class B common stock on October 1, 2025. A portion of shares, 7,262,330, were withheld by the company to cover required tax withholding in connection with the settlement. The filing also shows a gift of 3,691,901 Class B shares to a charitable organization controlled by the reporting person and spouse; those shares were transferred without consideration and are no longer beneficially owned by them. The Form 4 notes a prior administrative correction (previously reported as 57,183 RSUs) and explains the conversion mechanics between Class B and Class A shares under the company charter.

Brian Logan Beirne, Chief Legal Officer and Director of Strive, Inc. (ASST), reported the settlement of time‑vested restricted stock units into common stock on October 1, 2025. The filing discloses the conversion/settlement of 87,903 RSUs that yielded 87,903 Class A shares and an additional 494,430 RSUs that yielded 494,430 Class A shares, resulting in a reported total of 582,333 Class A shares beneficially owned following the transactions. The filing also shows 228,393 shares of Class B common stock were withheld by the registrant to satisfy tax withholding obligations in connection with RSU settlement. The RSUs originally time‑vested on June 15, 2025, and were settled on the October date; the report states the reporter did not voluntarily sell any shares in these transactions.

Strive, Inc. filed an 8-K reporting material disclosures tied to its proposed merger with Semler Scientific. The filing lists specific risks that could affect completion and expected benefits of the transaction, including the right of one or both parties to terminate the merger agreement, potential failure to satisfy closing conditions, and pending or possible litigation that could influence the outcome. The company warns that anticipated benefits such as cost savings and strategic gains may not be realized, and highlights risks from implementing Bitcoin treasury strategies, integration challenges, dilution from additional Class A share issuance, customer or employee reactions, and market or macroeconomic factors.

Strive, Inc. received a joint Schedule 13G disclosing that Graham-related reporting persons and Kenneth Tropin beneficially own a combined 37,037,038 shares of Class A common stock, representing 9.66% of the outstanding class on a basis that assumes exercise of warrants for 18,518,519 shares. The filing breaks ownership across entities: Graham Macro Strategic Ltd. holds 15,740,741 shares (plus warrants for the same amount), Graham Credit Opportunities Ltd. holds 2,777,778 shares (plus identical warrants), and the aggregate positions are reported as shared voting and dispositive power. The filers certify the holdings were not acquired to influence control. The statement lists issuer headquarters in Dallas and is signed on September 22, 2025 by authorized parties.

Benjamin Werkman, identified as a director of Strive, Inc. (ASST), submitted an initial Form 3 reporting that he does not beneficially own any securities of the issuer. The filing indicates it is an initial ownership statement under Section 16 and includes a power of attorney exhibit. The form was signed by an attorney-in-fact on behalf of the reporting person, and no non-derivative or derivative securities are listed on the statement.

Roy Avik, identified as a director of Strive, Inc. (ticker: ASST), filed an initial Form 3 reporting the event dated 09/12/2025. The filing states that no securities are beneficially owned by the reporting person. The submission includes an Exhibit 24 power of attorney and was signed by Brian Logan Beirne as attorney-in-fact on 09/22/2025. The form lists the reporting person’s business address as C/O Strive, Inc., 200 Crescent Court Suite 1400, Dallas, TX 75201. No derivative or non-derivative securities, ownership amounts, or exercise details are reported.